Henriëtte de Loor - Concepedia

Author

Henriëtte de Loor

Also Known As

H De Loor, H de Loor, H. de Loor, Henriette De Loor, Henriette De loor, Henriette Loor, Henriette de Loor, Henriette de Loor, Henriëtte de Loor, Jetty De Loor

Publications

Citations

H-Index

Concepts

All Affiliations

KU Leuven Inserm Assistance Publique – Hôpitaux de Paris Université Paris Cité Karolinska Institutet

About

Henriëtte de Loor is an author at KU Leuven specializing in medicine, nephrology, and urology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	16	913
2	Natural Sciences	3	3	193
3	Public Health	2	2	66
4	Social Sciences	1	1	79
5	Allergy	1	1	23

Henriëtte de Loor

Publications

2.8K

Citations

H-Index

Page 1

	Year	Citations
p-Cresol and Cardiovascular Risk in Mild-to-Moderate Kidney Disease Björn Meijers, Kathleen Claes, Bert Bammens, Clinical Journal of the American Society of Nephrology	2010	303
Microbiota-Derived Phenylacetylglutamine Associates with Overall Mortality and Cardiovascular Disease in Patients with CKD Ruben Poesen, Kathleen Claes, Pieter Evenepoel, Journal of the American Society of Nephrology	2016	208
Gas Chromatographic–Mass Spectrometric Analysis for Measurement of p-Cresol and Its Conjugated Metabolites in Uremic and Normal Serum Henriëtte de Loor, Bert Bammens, Pieter Evenepoel, Clinical Chemistry Renal PathologyConjugated P -CresolRenal FunctionGas ChromatographySerum Pools	2005	182
p-Cresyl Sulfate and Indoxyl Sulfate in Hemodialysis Patients Björn Meijers, Henriëtte de Loor, Bert Bammens, Clinical Journal of the American Society of Nephrology	2009	167
Natural killer cell infiltration is discriminative for antibody-mediated rejection and predicts outcome after kidney transplantation Saleh Yazdani, Jasper Callemeyn, Stéphane Gazut, Kidney International	2018	152
In Vivo CYP3A4 Activity, CYP3A5 Genotype, and Hematocrit Predict Tacrolimus Dose Requirements and Clearance in Renal Transplant Patients Hylke de Jonge, Henriëtte de Loor, Kristin Verbeke, Clinical Pharmacology & Therapeutics	2012	119
Albumin is the main plasma binding protein for indoxyl sulfate and <i>p</i>‐cresyl sulfate Liesbeth Viaene, Pieter Annaert, Henriëtte de Loor, Biopharmaceutics & Drug Disposition Dialysis TherapyChemical BiologyGlomerulonephritisRenal FunctionBinding Site	2013	118
Current target ranges of mycophenolic acid exposure and drug-related adverse events: A 5-year, open-label, prospective, clinical follow-up study in renal allograft recipients Dirk Kuypers, Hylke de Jonge, Maarten Naesens, Clinical Therapeutics UrologyTransplantationCurrent Target RangesKidney TransplantDrug-related Adverse Events	2008	112
The Influence of Prebiotic Arabinoxylan Oligosaccharides on Microbiota Derived Uremic Retention Solutes in Patients with Chronic Kidney Disease: A Randomized Controlled Trial Ruben Poesen, Pieter Evenepoel, Henriëtte de Loor, PLoS ONE	2016	103
Transcriptional Changes in Kidney Allografts with Histology of Antibody-Mediated Rejection without Anti-HLA Donor-Specific Antibodies Jasper Callemeyn, Evelyne Lerut, Henriëtte de Loor, Journal of the American Society of Nephrology	2020	97

Page 1